{"alopecia": 3.44, "dermatitis": 22.3, "dermatitis acneiform": 188.31, "disease progression": 4.03, "dry skin": 12.37, "ejection fraction decreased": 32.47, "folliculitis": 44.69, "malignant neoplasm progression": 19.07, "metastatic malignant melanoma": 296.29, "off label use": 2.16, "paronychia": 137.06, "product use in unapproved indication": 52.16, "product use issue": 20.19, "rash": 5.07, "skin toxicity": 61.28}